Change - Announcement of Cessation::Announcement for the Resignation of Director - Loh Chang Kaan

Issuer & Securities

Issuer/ Manager
TERRATECH GROUP LIMITED
Securities
TERRATECH GROUP LIMITED - KYG8763X1189 - 1D5
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
05-May-2017 02:00:04
Status
New
Announcement Sub Title
Announcement for the Resignation of Director - Loh Chang Kaan
Announcement Reference
SG170505OTHRD3AG
Submitted By (Co./ Ind. Name)
Zhang Da (Kenny Zhang)
Designation
Chief Financial Officer
Effective Date and Time of the event
04/05/2017 23:00:00
Description (Please provide a detailed description of the event in the box below)
Resignation of Dr. Loh Chang Kaan as Chief Executive Officer and Executive Director of the Company

Additional Details

Name Of Person
Loh Chang Kaan
Age
48
Is effective date of cessation known?
Yes
If yes, please provide the date
04/05/2017
Detailed Reason (s) for cessation
Further to the circular issued to the Company's shareholders on 29 March 2017 ("Circular"), following Completion of the Proposed Transactions (both terms as defined in the Circular), Dr Loh Chang Kaan has resigned as part of the reconstitution of the composition of the Board of Directors of the Company.

Based on its enquiries, the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd., is satisfied that, other than as disclosed in this announcement, there are no other material reasons for the cessation of Dr Loh Chang Kaan as Director of the Company.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
15/03/2013
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
4
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
4
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Executive Officer and Executive Director
Role and responsibilities
Executive

Dr. Loh Chang Kaan is responsible for the overall management and day-to-day operations of the Group.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
N.A.
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
Dr. Loh Chang Kaan holds 40,437 ordinary shares (on a post-consolidated basis) in the issued and paid-up share capital of the Company.
Past (for the last 5 years)
1. Biotech Group Pte. Ltd.
2. Biotech Pharmaceutical (Singapore) Pte. Ltd.
3. Cambridge Education Group Pte. Ltd.
4. Tritech Group Limited
5. Presscrete Engineering Pte Ltd
6. Tritech Engineering & Testing (Singapore) Pte Ltd
7. Tritech Geotechnic Pte Ltd
8. Tritech Instruments Pte. Ltd.
9. Tritech Consultants Pte. Ltd.
10. Tritech Water Technologies Pte. Ltd.
11. TGL Engineering Group Pte. Ltd.
12. Terra Tritech Engineering (M) Sdn. Bhd
Present
1. Terratech Resources Pte. Ltd.
2. CEP Resources Entity Sdn. Bhd.
3. Qingdao Terratech Resources Co., Ltd.
4. Shaanxi Hengyu Architectural Interior Engineering Co., Ltd.

Upon Completion of the Proposed Transactions, Dr. Loh Chang Kaan will also resign from the boards and as the legal representative (where applicable) of the Company's subsidiaries.